234 related articles for article (PubMed ID: 25467005)
1. Effects of a dietary intervention on gastrointestinal symptoms after prostate cancer radiotherapy: long-term results from a randomized controlled trial.
Pettersson A; Nygren P; Persson C; Berglund A; Turesson I; Johansson B
Radiother Oncol; 2014 Nov; 113(2):240-7. PubMed ID: 25467005
[TBL] [Abstract][Full Text] [Related]
2. Effects of a dietary intervention on acute gastrointestinal side effects and other aspects of health-related quality of life: a randomized controlled trial in prostate cancer patients undergoing radiotherapy.
Pettersson A; Johansson B; Persson C; Berglund A; Turesson I
Radiother Oncol; 2012 Jun; 103(3):333-40. PubMed ID: 22633817
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life in men after treatment of localized prostate cancer with external beam radiotherapy combined with (192)ir brachytherapy: a prospective study of 93 cases using the EORTC questionnaires QLQ-C30 and QLQ-PR25.
Wahlgren T; Brandberg Y; Häggarth L; Hellström M; Nilsson S
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):51-9. PubMed ID: 15337539
[TBL] [Abstract][Full Text] [Related]
4. The impact of gastrointestinal and genitourinary toxicity on health related quality of life among irradiated prostate cancer patients.
Schaake W; Wiegman EM; de Groot M; van der Laan HP; van der Schans CP; van den Bergh AC; Langendijk JA
Radiother Oncol; 2014 Feb; 110(2):284-90. PubMed ID: 24411226
[TBL] [Abstract][Full Text] [Related]
5. Quality of life after low-dose rate-brachytherapy for prostate carcinoma - long-term results and literature review on QLQ-C30 and QLQ-PR25 results in published brachytherapy series.
Buergy D; Schneiberg V; Schaefer J; Welzel G; Trojan L; Bolenz C; Wenz F
Health Qual Life Outcomes; 2018 Jan; 16(1):21. PubMed ID: 29357874
[TBL] [Abstract][Full Text] [Related]
6. Promising long-term health-related quality of life after high-dose-rate brachytherapy boost for localized prostate cancer.
Wahlgren T; Nilsson S; Lennernäs B; Brandberg Y
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):662-70. PubMed ID: 17499452
[TBL] [Abstract][Full Text] [Related]
7. Patient-reported gastrointestinal symptoms among long-term survivors after radiation therapy for prostate cancer.
Alsadius D; Olsson C; Pettersson N; Tucker SL; Wilderäng U; Steineck G
Radiother Oncol; 2014 Aug; 112(2):237-43. PubMed ID: 25201126
[TBL] [Abstract][Full Text] [Related]
8. Health-related quality of life in I-125 prostate brachytherapy patients treated with and without volume-reducing hormone therapy: results of a short-term prospective study.
Mols F; Stijns P; Dankaart B; Houterman S; Vingerhoets A; Hendrikx A
J Endourol; 2009 Jan; 23(1):153-9. PubMed ID: 19118465
[TBL] [Abstract][Full Text] [Related]
9. Quality of life and symptoms in a randomized trial of radiotherapy versus deferred treatment of localized prostate carcinoma.
Fransson P; Damber JE; Tomic R; Modig H; Nyberg G; Widmark A
Cancer; 2001 Dec; 92(12):3111-9. PubMed ID: 11753990
[TBL] [Abstract][Full Text] [Related]
10. The impact of acute urinary retention after iodine-125 prostate brachytherapy on health-related quality of life.
Roeloffzen EM; Hinnen KA; Battermann JJ; Monninkhof EM; van Roermund JG; van Gellekom MP; Frank SJ; van Vulpen M
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1322-8. PubMed ID: 19939578
[TBL] [Abstract][Full Text] [Related]
11. Long-term Toxicity and Health-related Quality of Life after Single-fraction High Dose Rate Brachytherapy Boost and Hypofractionated External Beam Radiotherapy for Intermediate-risk Prostate Cancer.
Shahid N; Loblaw A; Chung HT; Cheung P; Szumacher E; Danjoux C; Sankreacha R; Zhang L; Deabreu A; Mamedov A; Morton G
Clin Oncol (R Coll Radiol); 2017 Jul; 29(7):412-420. PubMed ID: 28190638
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality-of-life changes due to high-dose-rate brachytherapy, low-dose-rate brachytherapy, or intensity-modulated radiation therapy for prostate cancer.
Strom TJ; Cruz AA; Figura NB; Shrinath K; Nethers K; Mellon EA; Fernandez DC; Saini AS; Hunt DC; Heysek RV; Wilder RB
Brachytherapy; 2015; 14(6):818-25. PubMed ID: 26452602
[TBL] [Abstract][Full Text] [Related]
13. The effect of high dose rate brachytherapy in combination with external beam radiotherapy on men's health-related quality of life and sexual function over a 2 year time span.
Conaglen HM; de Jong D; Hartopeanu C; Conaglen JV; Tyrie LK
Clin Oncol (R Coll Radiol); 2013 Mar; 25(3):197-204. PubMed ID: 23183305
[TBL] [Abstract][Full Text] [Related]
14. Assessing patients' perceived bother from the gastrointestinal side effects of radiotherapy for localized prostate cancer: initial questionnaire development and validation.
Pettersson A; Turesson I; Persson C; Johansson B
Acta Oncol; 2014 Mar; 53(3):368-77. PubMed ID: 23957649
[TBL] [Abstract][Full Text] [Related]
15. Long-term toxicity and quality of life up to 10 years after low-dose rate brachytherapy for prostate cancer.
Emara AM; Chadwick E; Nobes JP; Abdelbaky AM; Laing RW; Langley SE
BJU Int; 2012 Apr; 109(7):994-1000. PubMed ID: 21854533
[TBL] [Abstract][Full Text] [Related]
16. Pudendal nerve injury impairs anorectal function and health related quality of life measures ≥2 years after 3D conformal radiotherapy for prostate cancer.
Yeoh EE; Botten R; Di Matteo A; Tippett M; Hutton J; Fraser R; Dinning PG; Wattchow D
Acta Oncol; 2018 Apr; 57(4):456-464. PubMed ID: 29139310
[TBL] [Abstract][Full Text] [Related]
17. Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial.
Aluwini S; Pos F; Schimmel E; van Lin E; Krol S; van der Toorn PP; de Jager H; Dirkx M; Alemayehu WG; Heijmen B; Incrocci L
Lancet Oncol; 2015 Mar; 16(3):274-83. PubMed ID: 25656287
[TBL] [Abstract][Full Text] [Related]
18. 3-D conformal treatment of prostate cancer to 74 Gy vs. high-dose-rate brachytherapy boost: a cross-sectional quality-of-life survey.
Vordermark D; Wulf J; Markert K; Baier K; Kölbl O; Beckmann G; Bratengeier K; Noe M; Schön G; Flentje M
Acta Oncol; 2006; 45(6):708-16. PubMed ID: 16938814
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life up to six years after (125)I brachytherapy for early-stage prostate cancer.
Roeloffzen EM; Lips IM; van Gellekom MP; van Roermund J; Frank SJ; Battermann JJ; van Vulpen M
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1054-60. PubMed ID: 20097486
[TBL] [Abstract][Full Text] [Related]
20. Effects of a nutrition intervention on acute and late bowel symptoms and health-related quality of life up to 24 months post radiotherapy in patients with prostate cancer: a multicentre randomised controlled trial.
Forslund M; Ottenblad A; Ginman C; Johansson S; Nygren P; Johansson B
Support Care Cancer; 2020 Jul; 28(7):3331-3342. PubMed ID: 31758324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
